These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 15867214

  • 1. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G.
    Clin Cancer Res; 2005 May 01; 11(9):3205-9. PubMed ID: 15867214
    [Abstract] [Full Text] [Related]

  • 2. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N, Maruyama S, Oyama K, Horie Y, Kohno M, Noma E, Sakaguchi S, Nagashima M, Kudo M, Kishimoto Y, Kawasaki H, Hasegawa J, Shiota G.
    Oncology; 2007 May 01; 72 Suppl 1():45-51. PubMed ID: 18087181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y, Li Q, Liu N, Song T, Liu Z, Guo R, Meng L.
    Hepatogastroenterology; 2008 May 01; 55(88):2200-6. PubMed ID: 19260505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar 01; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 12. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 13. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Nov 01; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 14. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 15. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH.
    Acta Otolaryngol; 2005 Apr 15; 125(4):409-14. PubMed ID: 15823813
    [Abstract] [Full Text] [Related]

  • 16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 17. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W, Yao DF, Qiu LW, Wu XH, Yao M, Su XQ, Zou L.
    Hepatobiliary Pancreat Dis Int; 2005 Nov 15; 4(4):544-9. PubMed ID: 16286259
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 15; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 19. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 15; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 20. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D, Zhai W, Zhu T, Zhu H, Ling Y.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul 15; 9 Suppl():79-81. PubMed ID: 11509149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.